We are MedFluid
We are committed to optimizing the quality of patient-specific medication of infectious disease
We apply microfluidics as our core technique to develop an in vitro diagnostic (IVD) system to support the precision medicine of antibiotics. Targeting the emergence of antimicrobial resistance (AMR) which is literally one of the ten threats to the global health in 2019 according to WHO. Our system, fAST, can carry out rapid bacteria identification within 1.5 hours, following by a multiple antibiotics combination test within 5 hours. To conclude, we are the fastest and first-in-class system in the market that can optimize three different kind of antibiotics combination to provide clinicians with accurate and personalized results.
According to a global research, 50% usage of antibiotics is inappropriate, and empirical treatment is one of the main causes. Empirical treatment usually gives 2~3 antibiotics at the same time to suppress unknown bacteria. However, there is no such medical device in the market that can conduct antibiotics combination test to either confirm or predict if the combination is effective. Moreover, the current time-consuming procedure for antimicrobial susceptibility test (AST) needs to be addressed urgently.
According to WHO, antimicrobial resistance is literally one of the ten threats to global health in 2019. It is happening around the world and in North America alone, have more the 2m cases and 23 thousands deaths.
Software & Hardware
We have the best partners from various industries